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Abstract 1 
Carbon monoxide (CO) modulates mitochondrial respiration but the mechanisms involved 2 
are not completely understood. The aim of the present study was to investigate the acute effects of 3 
CO on bioenergetics and metabolism in intact EA.hy926 endothelial cells using live cell imaging 4 
techniques. CORM-401, a compound that liberates CO, reduced ATP production from glycolysis and 5 
induced a mild mitochondrial depolarization, increase mitochondrial calcium and activation of 6 
complexes I- and II-dependent mitochondrial respiration leading to ATP production through 7 
increased oxidative phosphorylation. Our results show that non-activated endothelial cells rely 8 
primarily on glycolysis, but in the presence of CO, mitochondrial Ca2+ increases and activates 9 
respiration that shift metabolism of endothelial cells from glycolysis- to oxidative phosphorylation–10 
derived ATP production. 11 
Keywords: 12 
Carbon monoxide, CO-RM, endothelium, respiration, oxidative phosphorylation, glycolysis 13 
Abbreviations: CO, carbon monoxide; CO-RMs, CO-releasing molecules; CORM-401, 14 
Mn(CO)4{S2CNMe(CH2CO2H)}; iCORM-401, inactive CORM-401; NAD+/NADH, nicotinamide adenine 15 
dinucleotide, respectively oxidised/reduced form; FAD/FADH2, flavin adenine dinucleotide, 16 
respectively oxidised/reduced form; ETC, electron transport chain; ATP, adenosine triphosphate; 17 
ROS; IAA, iodoacetic acid; m, mitochondrial membrane potential; FCCP, carbonyl cyanide 4-18 
(trifluoromethoxy)phenylhydrazone; Rh123, Rhodamine 123; TMRM, tetramethylorhodamine; HET, 19 
hydroethidium; ECs, endothelial cells; PDH, pyruvate dehydrogenase; PFKFB3, phosphofructokinase/ 20 
fructosebisphosphatase; OXPHOS, oxidative phosphorylation; NO, nitric oxide; 21 
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 22 
1. Introduction 23 
There is overwhelming evidence that endogenous carbon monoxide (CO) affords beneficial 24 
antioxidant, anti-inflammatory and cytoprotective effects that could be mimicked by carbon 25 
monoxide-releasing molecules (CO-RMs) [1–3]. Indeed, CO liberated from CO-RMs has been shown 26 
to exert cardio- and vaso-protective effects, as well anti-thrombotic, anti-platelet and anti-27 
inflammatory effects [4–9]. 28 
The mechanisms of action of CO derived from CO-RMs are not well understood. A series of 29 
targets responsive to CO has been identified including guanylate cyclase, mitochondrial cytochromes, 30 
potassium channels, NO synthase, NADPH oxidase or transcription factors such as BACH1 or NPAS2 31 
[3,10–12]. The peculiar feature of all these CO-responsive targets is that they contain a heme moiety 32 
or a transition metal as a prosthetic group. Taking into consideration that CO binds with a high 33 
affinity to Fe(II)-heme, it is conceivable that the mitochondrial electron transport chain (ETC), which 34 
consists of a number of heme-containing proteins, represents a suitable cellular compartment 35 
whereby CO could transduce many of its known physiological effects. Despite some of the functional 36 
consequences of CO on mitochondrial bioenergetics have been reported, the specific molecular 37 
target(s) and the mode of action of CO within the ETC still remain to be fully investigated [13–19]. At 38 
high concentrations, CO is known to inhibit mitochondrial respiration as it strongly competes with 39 
oxygen for the binding to cytochrome c oxidase [17–20]. However, in a couple of recent studies 40 
conducted mainly on isolated mitochondrial preparations, it was demonstrated that CO, delivered at 41 
low micromolar concentrations using CO-RMs or CO gas, uncoupled mitochondrial respiration and 42 
increased oxygen consumption rate [14–16]. Lo Iacono et al [14] reported that the uncoupling effect 43 
induced by CO was associated with a gradual decrease in mitochondrial membrane potential over 44 
time and was partially reversed by inhibition of complex II activity. Long et al. [15] demonstrated that 45 
CO activated the phosphate carrier in the inner mitochondrial membrane leading to an increase in 46 
phosphate and proton transport inside mitochondria that contributed to the uncoupling effects of 47 
CO. Although Reiter et al. [21] and Wegiel et al. [22] previously showed that in intact cells CO also 48 
accelerated oxygen consumption rate, these authors did not elucidate the mechanisms of this effect. 49 
In our recent study we found that in intact endothelial cells CO liberated from CORM-401, a new 50 
manganese-containing CO releaser [23], induced an increase in oxygen consumption rate (OCR) that 51 
was accompanied by inhibition of glycolysis (extracellular acidification rate, ECAR) and a mild 52 
uncoupling effect as evidenced by an increase in proton leak [24]. Furthermore, CORM-401 53 
decreased the mitochondrial reserve capacity and enhanced non-mitochondrial respiration. Blockade 54 
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of mitochondrial large-conductance calcium-regulated potassium ion channels (mitoBKCa) markedly 55 
attenuated the increase in OCR promoted by CORM-401 without affecting ECAR. These results 56 
suggested that in intact endothelial cells CO induced a two-component metabolic response: 57 
uncoupling of mitochondrial respiration, dependent on activation of mitochondrial BKCa channels, 58 
and inhibition of glycolysis independent of mitoBKCa channels.  59 
In order to better understand this two-component metabolic response induced by CO in the 60 
endothelium, here we investigated the acute effect of CO on bioenergetics in intact endothelial cells 61 
using live cell imaging techniques. Taking advantage of this approach we evaluated the immediate 62 
effects of CO on the activity of mitochondrial complex I and II and investigated whether this effects 63 
of CO is linked to changes in ATP synthesis, ROS production and mitochondrial Ca2+ flux. 64 
65 
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 66 
2. Materials and methods 67 
2.1. Reagents 68 
Dulbecco’s Modified Eagle Medium (DMEM), fetal bovine serum (FBS), GlutaMAX, HAT 69 
supplement, penicillin/streptomycin, sodium pyruvate, and trypsin were obtained from Gibco. 70 
Oligomycin, carbonyl cyanide 4-(trifluoromethoxy)phenylhydrazone (FCCP), sodium cyanide, 71 
iodoacetic acid (IAA), manganese (II) sulfate (MnSO4) were obtained from Sigma. Fluorescent dyes: 72 
Rhodamine 123, Tetramethylorhodamine (TMRM), Hydroethidium (HET) were obtained from 73 
Invitrogen. The Effectene Transfection kit was obtained from Qiagen. CORM-401 was synthesized as 74 
described previously (Crook 2011). All experiments were performed with using 30 µM CORM-401, 75 
selected based on our previous work [24] as concentration at which released carbon monoxide 76 
induces a slight acceleration of oxygen consumption rate in EA.hy926 cells. 77 
 78 
2.2. Cell culture 79 
The hybridoma endothelial EA.hy926 cell line, formed by fusion of human umbilical vein 80 
endothelial cells (HUVEC) with the A549 human lung carcinoma cell line, was kindly provided by Dr. 81 
C-J Edgell (Department of Pathology, University of North Carolina, Chapel Hill, NC, USA) [25]. Cells 82 
were propagated using three weekly feedings of DMEM containing 10% FBS, 1 g/l glucose, 110 mg/l 83 
sodium pyruvate, 2 mM GlutaMAX™, antibiotics (100 IU penicillin, 100 μg/ml streptomycin) and 2% 84 
HAT Supplement. Cultures were maintained at 37 °C in a fully humidified atmosphere of 5% CO2 in 85 
air. Cells were confirmed to be contamination-free. For live cell imaging analysis, cells were plated 86 
into 25 mm coverslips in six-well plates to get a density of 80-100%. Before the experiments cells 87 
were washed one time with HBSS buffer (156 mM NaCl, 3 mM KCl, 1.25 mM KH2PO4, 2 mM MgSO4, 2 88 
mM CaCl2, 10 mM glucose, 10 mM HEPES, pH 7.35) and placed into the chamber for staining with a 89 
fluorescent dye before recording. 90 
2.3. Imaging of m, NADH, FAD, ROS generation, intracellular pH and ATP level 91 
For the measurement of m, cells were loaded with 1 µg/ml rhodamine123 (Rh123) for 30 92 
min at room temperature, and the dye was washed prior to the experiment. An increase in the 93 
Rh123 signal reflects mitochondrial depolarization. For the measurement of m using confocal 94 
microscopy, cells were loaded with 25 nM tetramethyl rhodamine methylester (TMRM) for 40 min at 95 
room temperature and the fluorescent indicator was present in all solutions during the experiment. 96 
A decrease in TMRM signal reflects mitochondrial depolarization. 97 
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Measurements of NADH autofluorescence were performed by using excitation light of a 98 
wavelength 360 nm and emitted fluorescence light was reflected through a 455 nm long-pass filter 99 
[26]. FAD autofluorescence was monitored using a confocal microscopy. Excitation at 454 nm was 100 
performed using an Argon laser line and fluorescence was measured from 505 to 550 nm. 101 
The assessment of ROS generation was performed using hydroethidine (HET) (2 µM), which 102 
was present in all solutions throughout the experiments. No pre-loading was used to limit the 103 
intracellular accumulation of oxidized products.  104 
Intracellular ATP levels were assessed by confocal microscopy. Briefly, Ea.hy926 cells were 105 
transfected with a genetically encoded ATP indicator AT1.03 cDNA [27] using an Effectene 106 
transfection reagent (Qiagen). AT.103 measures only free ATP and not Mg2+-bound ATP. One day 107 
after transfection, cells were subjected to imaging and ratio-metric analysis of the yellow- (λex=405 108 
nm,  λem=515-580 nm) and cyan-fluorescent (λex=405 nm,  λem=460-510 nm) proteins was performed.  109 
The energy capacity of cells was assessed by measuring the time needed for total ATP 110 
consumption after treatment of cells with a combination of inhibitors of glycolysis (20 µM iodoacetic 111 
acid, IAA) and oxidative phosphorylation (1 mM NaCN), which blocked ATP production and lead to 112 
ATP depletion. Upon hydrolysis of ATP magnesium (Mg2+) is released from MgATP, and therefore live 113 
cell imaging of cellular free magnesium ([Mg2+]c) using the Mg2+-sensitive fluorescent probe MagFura-114 
2 can be used as an indicator of ATP consumption [28,29]. For the measurement of free [Mg2+]c level 115 
cells were loaded with 5 µM MagFura-2 and 0.005 % Pluronic for 30 min at room temperature. A 116 
ratio of emission intensity at 515 nm was determined when the dye was excited at 340 nm versus 117 
380 nm 118 
Fluorescence measurements were performed using either a epifluorescence inverted 119 
microscope equipped with a cooled CCD camera or with a Zeiss (Oberkochen, Germany) 710 VIS 120 
CLSM. To achieve reproducible data the cells from periphery of the slide were excluded from 121 
analysis. 122 
Confocal images were obtained with using 40x or 63x oil immersion objective. Excitation was 123 
measured from 505 to 550 nm. Illumination intensity was kept to a minimum (at 0.1 – 0.2% of laser 124 
output) to avoid phototoxicity and the pinhole set to give an optical slice of ~2µm. 125 
2.4. Analysis of 2-hydroxyethidium (2-OH-E+) by HPLC with fluorescence and UV-visible absorption 126 
detection 127 
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Detection of 2-hydroxyethidium (2-OH-E+), a specific product of superoxide (O2•-) reaction 128 
with hydroethidine (HET) in cellular system was performed according to a modified protocol 129 
described by [30]. Briefly, confluent EA.hy926 cells (85 mm dishes) were incubated for 30 min with 130 
10 µM HET. Extraction of hydroethidine derivatives were analysed by HPLC with fluorescence 131 
detection performed using UFLC Nexera system (Shimadzu, Kyoto, Japan). Chromatographic 132 
separation was carried out on a Kinetex C18 analytical column (4.6x100mm, 2.6m, Phenomenex, 133 
Torrance, CA, USA) with the oven temperature set at 40 °C. The autosampler temperature was 134 
maintained at 4 °C. The mobile phase consisted of acetonitrile (A) and water (B) both with an 135 
addition of 0.1 % trifluoroacetic acid with the following linear eluting steps: 0.0 min (A:B, 25/75, v/v) 136 
– 0.5 min (A:B, 25/75, v/v) – 8 min (A:B, 35/65, v/v) – 9 min (A:B, 95/5, v/v) – 11 min (A:B, 95/5, v/v) – 137 
12.0 min (A:B, 25/75, v/v) – 14.0 min (A:B, 25/75, v/v). The flow rate was set at 1 ml min-1. A sample 138 
volume of 50 μl was injected onto column. The linearity range of the method was 0.005-0.5 M. 139 
2.5. Statistics 140 
Statistical analysis was performed using a OriginPro 9.1 software (OriginLab Corporation). 141 
Results were expressed as means ± s.e.m. For statistical analysis One-way ANOVA with Benferroni’s 142 
Multiple Comparison Test was performed, P values provided in the legends. 143 
144 
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 145 
3. Results 146 
3.1. CORM-401 shifts ATP production from glycolysis to oxidative phosphorylation in endothelial 147 
cells.  148 
To verify the effect of CO on energy production in endothelial cells, we first measured 149 
cytosolic ATP concentration using a genetically encoded fluorescent ATP indicator (AT1.03). We 150 
found that after addition of the ATP-synthase inhibitor oligomycin (2 µg/ml), the ATP content in 151 
untreated EA.hy926 cells or in cells treated with an inactive CORM-401 that does not release CO 152 
(iCORM-401) remained almost unchanged. However, ATP rapidly decreased after inhibition of 153 
glycolysis with 20 µM iodoacetic acid (IAA, glyceraldehyde 3-phosphate dehydrogenase inhibitor; Fig. 154 
1A,B) indicating that endothelial cells rely mainly on glycolysis for ATP production [31,32]. In 155 
contrast, in endothelial cells treated with CO liberated from CORM-401, oligomycin induced a rapid 156 
(3 min) and significant decrease in intracellular ATP concentration that was further diminished after 157 
application of IAA (Fig. 1C). These results suggest that the contribution to ATP production by 158 
oxidative phosphorylation in endothelial cells is considerably increased in the presence of CO. To 159 
verify whether CO affected the energy capacity of the cell, we assessed the time period required for 160 
energetic collapse (i.e. total intracellular ATP pool depletion) and breakdown of calcium homeostasis 161 
[29] following simultaneous inhibition of glycolysis (IAA) and oxidative phosphorylation (NaCN, 162 
complex IV inhibitor). Live cell imaging of the fluorescent probe MagFura-2 was employed to assess 163 
the energy capacity of endothelial cells treated with CORM-401 or iCORM-401. Magnesium (Mg2+) is 164 
released from MgATP upon the hydrolysis of ATP, and therefore measurement of cellular free 165 
magnesium ([Mg2+]c) using the Mg2+-sensitive fluorescent probe MagFura-2 is an indicator of ATP 166 
consumption [28,29]. Treatment of cells with inhibitors of glycolysis and oxidative phosphorylation 167 
blocked ATP production in cells, which eventually lead to ATP depletion, subsequent Mg2+ release 168 
and MagFura-2 fluorescence increase (Fig. 2A-C). As shown in Fig. 2D CORM-401 did not affect the 169 
energy capacity of endothelial cells. 170 
3.2. CORM-401 induces mild depolarization of mitochondria.  171 
The regulatory effect of CORM-401 on endothelial metabolism was associated with a small 172 
(~20%) mitochondrial depolarization (Fig. 3A). Mitochondrial membrane potential (m) gradually 173 
decreased after addition of CORM-401 (note: the increase of Rh123 fluorescence shown in Fig. 3A 174 
corresponds to a decrease in m). Basal levels of m, which was measured with TMRM 10 min 175 
after incubation of endothelial cells with CORM-401, was reduced by 20% in comparison to untreated 176 
cells or cells treated with iCORM-401 (Fig. 3C-E). Application of FCCP (1 µM) at the end of 177 
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measurements caused a rapid and complete depolarization of mitochondria. As shown in Fig. 3B, 178 
iCORM-401 did not affect m, indicating that the depolarization of m observed after 179 
administration of CORM-401 was due to CO liberated by CORM-401. As the production of reactive 180 
oxygen species (ROS) generation is dependent on m, we then studied the acute effects of CORM-181 
401 on ROS generation using the hydroethidine (HET) fluorescence assay. CORM-401 did not change 182 
the rate of ROS production in endothelial cells throughout 30 min of incubation, which was also 183 
confirmed using live cells imaging technique (Fig. 3F) as well as HPLC-based measurements of 2-184 
hydroxyethidium (2-OH-E+, see Fig. 3G), a specific product of the reaction between superoxide (O2•-) 185 
and HET [30]. In contrast, 10 µM menadione, which is known to generate superoxide (positive 186 
control)[33], induced a marked increase in 2-OH-E+ in endothelial cells (Fig. 3G). 187 
Impaired mitochondrial respiration or high glycolytic activity can induce a switch of the F0-188 
F1-ATP synthase to work in reverse mode (as ATPase) in order to maintain m [29], we next 189 
examined whether ATP synthase activity was indeed affected by CORM-401. The F0-F1-ATP synthase 190 
inhibitor oligomycin was employed to test if CORM-401 affected the mechanism of m 191 
maintenance. Inhibition of ATP synthase in control endothelial cells induced a significant reduction in 192 
m (Fig. 4A) suggesting that F0-F1-ATPase was working in reverse mode (consuming ATP). These 193 
results confirm our observation (Fig. 1) that endothelial cells are highly glycolytic and maintain m 194 
using ATP produced in glycolysis. Importantly, pre-incubation of cells with CORM-401 for 20 min not 195 
only reduced m but also decreased the effect of oligomycin on TMRM signal (Fig. 4B). These data 196 
suggest that in endothelial cells the production of ATP predominantly from glycolytic sources is 197 
shifted to ATP synthesis derived mainly from mitochondrial oxidative phosphorylation in the 198 
presence of CO (Fig. 4B) and this effect is associated with a change in F0-F1-ATPase activity from 199 
reverse mode (ATPase) to ATP-production mode. 200 
3.3. CORM-401 activates complexes I and II of the electron transport chain (ETC).  201 
The effect of CORM-401 on the respiratory chain activity in endothelial cells was studied by 202 
measurement of NADH and FAD autofluorescence.  CORM-401 accelerated NADH consumption (Fig. 203 
5), induced a fall in NADH redox index, as the total mitochondrial pool of NADH did not change in 204 
comparison to the control conditions (iCORM-401; Fig. 5B, C). CORM-401 induced a decrease in 205 
NADH autofluorescence (induced by activation of complex I) and this was accompanied by an 206 
increase in FAD autofluorescence (induced by activation of the complex II, fig. 5D). These results 207 
indicate that not only complex I, but also complex II was activated by CO derived from CORM-401. 208 
However, changes in the activities of ETC complexes induced by CORM-401 were relatively rapid, and 209 
on the basis of this we hypothesized that this could be due to changes in mitochondrial calcium 210 
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handling in response to CO (Fig. 6). CORM-401 increased the calcium contents in the matrix of 211 
mitochondria as measured by x-rhod-1 fluorescence [34]. This increase in calcium levels may then be 212 
responsible for the increase in mitochondrial respiration and activation of the production of ATP by 213 
oxidative phosphorylation.  214 
215 
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4. Discussion 216 
In the present study we investigated the acute effects of CO liberated from CORM-401 on 217 
endothelial bioenergetics. We demonstrated that quiescent ECs rely mainly on glycolysis and 218 
maintain mitochondrial membrane potential by glycolysis-derived ATP and F0-F1-ATP synthase 219 
working in a reverse mode (ATPase). In contrast, addition of CO at low micromolar concentrations 220 
resulted in a mild uncoupling effect that was accompanied by a shift in endothelial metabolism from 221 
glycolysis to mitochondrial respiration leading to increased ATP production derived mainly from 222 
oxidative phosphorylation. These results indicate that CO fine-tunes the bioenergetic profile of 223 
endothelial cells, which may have important implications in both physiological and 224 
pathophysiological processes. 225 
The finding that CO induces activation of respiration under physiological conditions is 226 
intriguing and rather counterintuitive. In fact, high concentrations of CO potently inhibit complex IV 227 
activity within the ETC due to its high competition with oxygen for the binding site [17–20]. However, 228 
a number of reports have now emerged showing that CO delivered in controlled amounts does not 229 
inhibit respiration but rather promotes a transient increase in oxygen consumption in isolated 230 
mitochondria from various organs or different cell types including cardiomyocytes, astrocytes and 231 
hepatocytes [13–15,35,36]. The mechanisms responsible for this effect are at present not completely 232 
understood. We have demonstrated in one of our recent studies that CO in intact ECs exhibits two 233 
independent but simultaneous effects: acceleration of mitochondrial respiration mediated by 234 
activation of mitoBKCa channels and inhibition of glycolysis independent of mitoBKCa channels [24]. 235 
In the present report we confirmed that CO from CORM-401 increased mitochondrial respiration and 236 
demonstrated for the first time that this effect involved an increase in the activity of complexes I and 237 
II in ETC. Previously, in studies conducted on isolated rat heart mitochondria, Lo Iacono and 238 
colleagues found that CO released by CORM-3 at concentrations between 1 and 20 µM increased 239 
state 2 mitochondrial respiration through an uncoupling effect, although no direct effect was found 240 
on the activity of the ETC complexes [14]. However, treatment of isolated mitochondria with 241 
malonate, an inhibitor of complex II, reversed the increase in state 2 respiration induced by CORM-3 242 
suggesting that complex II activity, most likely indirectly, can be modulated by CO. In our study 243 
performed in intact endothelial cells, thus preserving the natural intracellular milieu, CO liberated by 244 
CORM-401 accelerated the consumption of NADH that is provided by the tricarboxylic acid (TCA) 245 
cycle. It is known that changes in the activity of the ETC complexes may affect the TCA cycle turnover 246 
through bidirectional feedback mechanisms on pyruvate dehydrogenase, which is regulated by 247 
NAD+/NADH ratio [37]. Accordingly, the results of the present study suggest that increased 248 
consumption of mitochondrial NADH induced by CO is linked to the activation of TCA. In this context, 249 
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it was interesting to observe that CO induced an increase in mitochondrial calcium content. Calcium 250 
activates diverse cellular ATP-consuming processes, as well as pyruvate dehydrogenase and other 251 
mitochondrial dehydrogenases orchestrating the supply of NADH to ETC. These enzymes provide a 252 
constant reducing power in the form of NADH that are utilized by the mitochondrial ETC to sustain 253 
energy demand [38]. Thus, although other mechanisms could also be involved [39,40], the activation 254 
of both complexes I and II by CO reported was linked here with a transient increase in mitochondrial 255 
calcium and concomitantly to an accelerated TCA turnover. Altogether, our results suggest that CO 256 
released by CORM-401 induces an activation of complexes I and II as a result of increased 257 
mitochondrial calcium content and subsequent acceleration of TCA cycle turnover. 258 
An interesting finding of this work was that the acute effects of CO on mitochondrial 259 
respiration were associated with a rapid metabolic shift from glycolysis to oxidative phosphorylation, 260 
which in turn did not affect the energy capacity of the cell. The inhibitory effect of CO on glycolysis is 261 
in accordance with the work published by Yamamoto et al. [41]. Authors reported that CO affected 262 
glycolysis by inhibition of cystathionie β-synthase and subsequent reduction in 263 
phosphofructokinase/fructosebisphosphatase type3 (PFKFB3) methylation leading to a shunt of 264 
glucose from glycolysis to the pentose phosphate pathway. Interestingly, PFKFB3 has been suggested 265 
as a key regulatory enzyme in the control of endothelial glycolysis [32,42,43]. The reprogramming of 266 
cells in energy production reported here occurred quite rapidly – as early as 3 min after addition of 267 
CORM-401 and was sustained for over 30 min (Fig. 1) - and constitutes qualitatively different 268 
response as observed previously [24] 50 min after addition of CORM-401. Accordingly, the different 269 
effects of CO in these two situations depended not only on CO concentration, but also on the time of 270 
exposure, suggesting that CO may have transient and sustained effects on mitochondrial function. 271 
Most importantly, our data presented here indicate that despite a partial inhibition of glycolysis by 272 
CO, endothelial cells rapidly adjust their metabolism to energetic demands. Thus, we demonstrated 273 
for the first time that CO at low concentrations is able to fine-tune endothelial cell metabolism. This 274 
effect may have an important physiological significance in the protective properties attributed to CO, 275 
which could function as intracellular regulator of metabolism in energy-consuming defensive 276 
processes against stress conditions. 277 
There are number of reports showing an increased production of ROS following exposure of 278 
cells and tissues to CO [12–14,18,22]. Here, we found that CO did not accelerate the production of 279 
ROS (Fig. 3F,G). These results, together with a mild decrease of mitochondrial membrane potential 280 
(m) (Fig. 3A) and an activation of complexes I and II (Fig. 5) highlight that CO at low concentrations 281 
has an effect on endothelial bioenergetics that is not linked to alterations in ROS production. 282 
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Mitochondrial membrane potential (m), which is usually maintained by cellular respiration 283 
[44], is a key component in the preservation of a mitochondrial function. Here, we demonstrated 284 
that after treatment with CORM-401 oligomycin diminished m (Fig. 4A) indicating that before 285 
addition of the inhibitor, m was partially maintained by hydrolysis of ATP delivered by cytoplasmic 286 
glycolysis and processed by F0-F1-ATP synthase working in reversed mode. At first, these results 287 
would indicate some serious dysfunction within the cells possibly due to an increased proton leak 288 
through the inner mitochondrial membrane [45]. However, ECs prefer glycolysis for ATP production 289 
(for review see [32]). Even though ECs possess functional mitochondria, glycolysis-derived ATP can be 290 
utilized for the maintenance of m in functional non-activated ECs. It is tempting to speculate that 291 
this is an adaptation of ECs to their role in the vasculature. In fact, m controls not only 292 
mitochondrial bioenergetic processes but also a transition between life and death [45,46]. In fact, 293 
preservation of m in the endothelium has to be supported by the ATP generating system that is 294 
independent of mitochondrial respiration, to avoid a collapse of m induced by endothelium-295 
derived NO. Similar mechanism of m control has also been observed in other cell types, which 296 
were able to maintain m by glycolytically-derived ATP after treatment with NO [47,48]. 297 
In conclusion, to our knowledge, we report here for the first time that CO delivered by 298 
CORM-401 induces an acute shift from glycolysis to OXOPHOS in endothelial cells while preserving 299 
their ATP producing capacity. CO increases the activity of complexes I and II in the mitochondrial ETC 300 
and slightly uncouples mitochondria most likely via a calcium-dependent mechanism. A progressive 301 
decrease in m, which we observed in ECs in response to CO, might be the result of multiple effects 302 
occurring in a successive fashion including uncoupling of mitochondrial respiration, proton leak and 303 
decreased availability of glycolytically generated ATP. CO-dependent regulation of bioenergetics in 304 
the endothelium may constitute an important adjusting mechanism that regulates energetic 305 
metabolism to maintain endothelial homeostasis. 306 
307 
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Figure Legends 464 
Figure 1 465 
CORM-401 shifts glycolysis to oxidative phosphorylation in ATP production. (A-C) Cytosolic ATP in 466 
EA.hy926 cells transfected with AT1.03 measured as a fluorescence ratio 527/475 nm in cells 467 
untreated (A; n = 8), treated with iCORM-401 (inactive ligand for CORM-401 + MnSO4; 30 µM; B; n = 468 
9) or CORM-401 (30 µM) – a compound releasing carbon monoxide (C; n = 14). 2 µg/ml oligomycin 469 
was used to inhibit oxidative phosphorylation, 20 µM iodoacetic acid (IAA) to inhibit glycolysis. Data 470 
are presented as means in a representative experiment. 471 
Figure 2 472 
CORM-401 does not affect energy capacity of cells. (A-C) EA.hy926 cells were untreated (A; n = 149), 473 
treated with 30 µM iCORM-401 (B; n = 145 cells) or 30 µM CORM-401 (C; n = 157 cells). ATP 474 
depletion was measured with using Mg-sensitive fluorescence probe Mag-Fura-2 after treatment of 475 
cells with inhibitors of glycolysis (20 µM iodoacetic acid, IAA) and oxidative phosphorylation (1 mM 476 
NaCN), which blocked ATP production in cells. Figures show traces from twelve representative cells in 477 
each. (D) Energy capacity reflecting ATP production in EA.hy926 cells measured as a time to cell lysis 478 
in response to NaCN (1 mM) and IAA (20 µM). Data are presented as means ± SEM. The differences 479 
were not statistically significant (P < 0.05). 480 
Figure 3 481 
CORM-401 induces slight mitochondrial depolarization. Mitochondrial membrane potential changes 482 
in time were determined in EA.hy926 cells treated with 30 µM CORM-401 (A, n = 35 cells) or 30 µM 483 
iCORM-401 (B, n = 73 cells) by Rhodamine-123 (10 µM) fluorescence in a dequenched mode. (C) 484 
Mitochondrial membrane potential 10 min after incubation of cells with CORM-401 or iCORM-401 in 485 
comparison to untreated control was determined by TMRM (25 nM) fluorescence in a quenched 486 
mode (data are presented as means ± SEM , P < 0.05). D and E are representative TMRM images of 487 
control and CORM-401 treated cells. (F) ROS generation under CORM-401 in comparison to iCORM-488 
401 treatment measured by live cells imaging of hydroethidine (2 µM) fluorescence. (G) 2-OH-E+ 489 
level in EA.hy926 cells: control or incubated for 30 min with 30 µM CORM-401, 30 µM iCORM-401 or 490 
10 µM menadione (as a positive control). Data are presented as means ± SEM of three independent 491 
experiments, three replicates in each experiment (**P < 0.01). 492 
Figure 4 493 
CORM-401 decreases participation of glycolysis-derived ATP in maintenance of m. Oligomycin 494 
null-point test was performed with using TMRM (25 nM). m was measured in control EA.hy926 495 
cells (A) or cells pre-incubated for 20 min with 30 µM CORM-401 (B). Oligomycin (2 µg/ml) was used 496 
to inhibit ATP synthase, FCCP (1 µM ) was used to depolarize mitochondria. Data are presented as 497 
means ± SEM. 498 
Figure 5 499 
20 
 
CORM-401 activates mitochondrial respiration in endothelial cells. (A) NADH autofluorescence was 500 
measured after treatment of EA.hy926 cells with 30 µM CORM-401 or 30 µM iCORM-401. FCCP (1 501 
µM) was used as an uncoupler to maximize mitochondrial respiration, whereas NaCN (1 mM) as an 502 
inhibitor of complex IV to inhibit mitochondrial respiration. Data present representative traces from 503 
three independent experiments. (B) NADH redox index reflects of the ratio of NADH is in its reduced 504 
form. Data represent means ± SEM of three independent experiments (**P < 0.005); CORM-401, n = 505 
98 cells; iCORM-401, n = 57 cells. (C) NADH pool was calculated as a difference in autofluorescence 506 
between two states of ETC: maximally accelerated after addition of FCCP and completely inhibited 507 
after addition of NaCN; it reflects a total amount of available mitochondrial NADH. (D) 508 
Autofluorescence of NADH and FAD measured simultaneously in EA.hy926 cells treated with CORM-509 
401 (n = 8 cells). Data are presented as means ± SEM. 510 
Figure 6 511 
CORM-401 increases mitochondrial calcium signal in EA.hy926 cells. (A) Changes in X-rhod-1 512 
fluorescence demonstrate an increase in calcium signal in mitochondria in live cells stimulated with 513 
30 µM CORM-401. Each trace represents the mitochondrial calcium level in a single endothelial cell.  514 
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